DE69132036D1 - Wirkstoff zur Behandlung der Drogenabhängigkeit - Google Patents

Wirkstoff zur Behandlung der Drogenabhängigkeit

Info

Publication number
DE69132036D1
DE69132036D1 DE69132036T DE69132036T DE69132036D1 DE 69132036 D1 DE69132036 D1 DE 69132036D1 DE 69132036 T DE69132036 T DE 69132036T DE 69132036 T DE69132036 T DE 69132036T DE 69132036 D1 DE69132036 D1 DE 69132036D1
Authority
DE
Germany
Prior art keywords
treatment
active ingredient
drug addiction
agents
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69132036T
Other languages
English (en)
Other versions
DE69132036T2 (de
Inventor
Theo Frans Meert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of DE69132036D1 publication Critical patent/DE69132036D1/de
Application granted granted Critical
Publication of DE69132036T2 publication Critical patent/DE69132036T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69132036T 1990-06-13 1991-06-05 Wirkstoff zur Behandlung der Drogenabhängigkeit Expired - Fee Related DE69132036T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53717590A 1990-06-13 1990-06-13

Publications (2)

Publication Number Publication Date
DE69132036D1 true DE69132036D1 (de) 2000-04-20
DE69132036T2 DE69132036T2 (de) 2000-12-21

Family

ID=24141527

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69132036T Expired - Fee Related DE69132036T2 (de) 1990-06-13 1991-06-05 Wirkstoff zur Behandlung der Drogenabhängigkeit

Country Status (14)

Country Link
EP (1) EP0461705B1 (de)
JP (1) JPH04230218A (de)
KR (1) KR920000321A (de)
AT (1) ATE190488T1 (de)
AU (1) AU637502B2 (de)
CA (1) CA2044423A1 (de)
CZ (1) CZ279872B6 (de)
DE (1) DE69132036T2 (de)
HU (1) HU208080B (de)
IE (1) IE911996A1 (de)
IL (1) IL98444A (de)
PT (1) PT97961B (de)
SK (1) SK278577B6 (de)
ZA (1) ZA914501B (de)

Also Published As

Publication number Publication date
CA2044423A1 (en) 1991-12-14
SK278577B6 (en) 1997-10-08
CS178091A3 (en) 1992-02-19
JPH04230218A (ja) 1992-08-19
IE911996A1 (en) 1991-12-18
PT97961A (pt) 1992-03-31
IL98444A (en) 1995-06-29
EP0461705B1 (de) 2000-03-15
KR920000321A (ko) 1992-01-29
HUT60628A (en) 1992-10-28
EP0461705A2 (de) 1991-12-18
EP0461705A3 (en) 1992-06-17
ATE190488T1 (de) 2000-04-15
DE69132036T2 (de) 2000-12-21
IL98444A0 (en) 1992-07-15
ZA914501B (en) 1993-02-24
PT97961B (pt) 1998-11-30
AU637502B2 (en) 1993-05-27
HU911971D0 (en) 1991-12-30
CZ279872B6 (cs) 1995-07-12
HU208080B (en) 1993-08-30
AU7832191A (en) 1991-12-19

Similar Documents

Publication Publication Date Title
NL970006I2 (nl) Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
MX9306831A (es) Nuevos compuestos heterociclicos.
WO1999012532A3 (en) Piperidine derivatives against malaria
DE68902209D1 (de) Imidazolin-derivate und verfahren zu deren herstellung.
FR2614618B1 (fr) Derives heterocycliques polycycliques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
ITMI911101A1 (it) Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IL88740A (en) Pharmaceutical compositions containing n-n-butyl deoxynojirimycin for treating aids
ATE263183T1 (de) A-500359-derivate
DE69132036D1 (de) Wirkstoff zur Behandlung der Drogenabhängigkeit
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso
DE68914600D1 (de) Kondensierte heterocyclische Derivate von 1,2,3,4-Tetrahydroacridin, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament.
NO20013480D0 (no) Legemiddel for törr hud
DK644487D0 (da) Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse
TH13808EX (th) อนุพันธ์ของพิเพอแรซิน และอนุพันธ์ของพิเพอริดิน
TH37152A (th) อนุพันธ์ ซับสทิทิวเทด 4-แอริลบิวทิริคแอซิด เป็นสารยับยั้ง แมทริกซ์ เมธัลลอโปรตีเอส

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee